197.40
BATS BZX Real-Time Price
As of 1:40pm ET
 -0.02 / -0.01%
Today’s Change
163.31
Today|||52-Week Range
201.23
+13.51%
Year-to-Date
AMGN Regular Dividend: AMGN began trading ex-dividend on 08/16/18. A $1.32 dividend will be paid to shareholders of record as of 08/17/18.

Today’s Trading

Previous close197.42
Today’s open197.65
Day’s range197.00 - 198.47
Volume32,217
Average volume (3 months)2,894,217
Market cap$126.4B
Data as of 1:40pm ET, 08/20/2018

Growth & Valuation

Earnings growth (last year)-73.73%
Earnings growth (this year)+10.28%
Earnings growth (next 5 years)+5.60%
Revenue growth (last year)+0.45%
P/E ratio53.2
Price/Sales5.61
Price/Book5.59

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences-0.45-0.62%
BIIBBiogen-2.31-0.67%
ILMNIllumina Inc-0.50-0.15%
----
Data as of 1:42pm ET, 08/20/2018

Financials

Next reporting dateOctober 24, 2018
EPS forecast (this quarter)$3.41
Annual revenue (last year)$22.8B
Annual profit (last year)$2.0B
Net profit margin8.69%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Esteban Santos
Corporate headquarters
Thousand Oaks, California

Forecasts